ROSEWOOD: A Phase II Randomized Study of Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients with Relapsed or Refractory Follicular Lymphoma

  1. Zinzani, P.L.
  2. Mayer, J.
  3. Flowers, C.R.
  4. Bijou, F.
  5. De Oliveira, A.C.
  6. Song, Y.
  7. Zhang, Q.
  8. Merli, M.
  9. Bouabdallah, K.
  10. Ganly, P.
  11. Zhang, H.
  12. Johnson, R.
  13. Martín García-Sancho, A.
  14. Provencio Pulla, M.
  15. Trněný, M.
  16. Yuen, S.
  17. Tilly, H.
  18. Kingsley, E.
  19. Tumyan, G.
  20. Assouline, S.E.
  21. Auer, R.
  22. Ivanova, E.
  23. Kim, P.
  24. Huang, S.
  25. Delarue, R.
  26. Trotman, J.
  27. Erakutsi egile guztiak +
Aldizkaria:
Journal of Clinical Oncology

ISSN: 1527-7755,  0732-183X

Argitalpen urtea: 2023

Alea: 41

Zenbakia: 33

Orrialdeak: 5107-5117

Mota: Biltzar ekarpena

DOI: 10.1200/JCO.23.00775 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak